Main pigmentary features and melanocortin 1 receptor (MC1R) gene polymorphisms in the population of the Canary Islands

International Journal of Dermatology

Volumn 47, Issue 8, 2008, Pages 806-811

  de misa, Ricardo F ^a   Pérez méndez, Lina I ^a   Hernández jiménez, José G ^a   Del Cristo Rodríguez, María ^a   Vilar, María Concepción ^a   Suárez, José ^a   Claveríe martín, Félix ^a  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MELANOCORTIN 1 RECEPTOR;

ADULT; ALLELE; ANALYZER; ARTICLE; AUSTRALIA; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DNA DETERMINATION; EYE COLOR; FEMALE; FRANCE; GENE FREQUENCY; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; GREECE; HAIR COLOR; HUMAN; ITALY; LENTIGO; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PHENOTYPE; POPULATION RESEARCH; POPULATION RISK; PREVALENCE; SEQUENCE ANALYSIS; SKIN CANCER; SKIN COLOR; SKIN PIGMENTATION; SPAIN; SUN EXPOSURE; WILD TYPE;

ADULT; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; EYE COLOR; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; HAIR COLOR; HUMANS; INCIDENCE; MALE; MASS SCREENING; MELANOMA; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTOR, MELANOCORTIN, TYPE 1; RISK ASSESSMENT; SKIN NEOPLASMS; SKIN PIGMENTATION; SPAIN; VARIATION (GENETICS);

EID: 48249090962     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03680.x     Document Type: Article

References (43)

1. Geller AC, Swetter SM, Brooks K, et al. Screening, early detection, and trends for melanoma: Current status (2000-2006) and future directions. J Am Acad Dermatol 2007; 57: 555-572.
2. Katsambas A, Nicolaidou E. Cutaneous malignant melanoma and sun exposure. Recent developments in epidemiology. Arch Dermatol 1996; 132: 444-450.
3. Beitner H, Norell SE, Ringborg U, et al. Malignant melanoma: aetiological importance of individual pigmentation and sun exposure. Br J Dermatol 1990; 122: 43-51.
4. Bliss JM, Ford D, Swerdlow AJ, et al. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: Systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE). Int J Cancer 1995; 62: 367-376.
5. Mountjoy KG, Robbins LS, Mortrud MT, et al. The cloning of a family of genes that encode the melanocortin receptors. Science 1992; 257: 1248-1251.
6. Harding RM, Healy E, Ray AJ, et al. Evidence for variable selective pressures at MC1R. Am J Hum Genet 2000; 66: 1351-1361.
7. Valverde P, Healy E, Jackson I, et al. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 1995; 11: 328-330.
8. Box NF, Wyeth JR, O'Gorman LE, et al. Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum Mol Genet 1997; 6: 1891-1897.
9. Smith R, Healy E, Siddiqui S, et al. Melanocortin 1 receptor variants in an Irish population. J Invest Dermatol 1998; 111: 119-122.
10. Kanetsky PA, Ge F, Najarian D, et al. Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach. Cancer Epidemiol Biomarkers Prev 2004; 13: 808-819.
11. Sturm RA, Box NF, Ramsay M. Human pigmentation genetics: The difference is only skin deep. Bioessays 1998; 20: 712-721.
12. Han J, Kraft P, Colditz GA, et al. Melanocortin 1 receptor variants and skin cancer risk. Int J Cancer 2006; 119: 1976-1984.
13. Valverde P, Healy E, Sikkink S, et al. The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Hum Mol Genet 1996; 5: 1663-1666.
14. Ichii-Jones F, Lear JT, Heagerty AH, et al. Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene. J Invest Dermatol 1998; 111: 218-221.
15. Palmer JS, Duffy DL, Box NF, et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: Is the association explained solely by pigmentation phenotype? Am J Hum Genet 2000; 66: 176-186.
16. Kennedy C, ter Huurne J, Berkhout M, et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001; 117: 294-300.
17. Bastiaens M, ter Huurne J, Gruis N, et al. The melanocortin-1-receptor gene is the major freckle gene. Hum Mol Genet 2001; 10: 1701-1708.
18. Fargnoli MC, Chimenti S, Keller G, et al. Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean population. Hum Mutat 2003; 21: 655.
19. Pastorino L, Cusano R, Bruno W, et al. Novel MC1R variants in Ligurian melanoma patients and controls. Hum Mutat 2004; 24: 103.
20. Matichard E, Verpillat P, Meziani R, et al. Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J Med Genet 2004; 41: E13.
21. Fargnoli MC, Altobelli E, Keller G, et al. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: A case-control study. Melanoma Res 2006; 16: 175-182.
22. Landi MT, Kanetsky PA, Tsang S, et al. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst 2005; 97: 998-1007.
23. Chaudru V, Laud K, Avril MF, et al. Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees. Cancer Epidemiol Biomarkers Prev 2005; 14: 2384-2390.
24. Flanagan N, Healy E, Ray A, et al. Pleiotropic effects of the melanocortin 1 receptor (MC1R) gene on human pigmentation. Hum Mol Genet 2000; 9: 2531-2537.
25. Stratigos AJ, Dimisianos G, Nikolaou V, et al. Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population. J Invest Dermatol 2006; 126: 1842-1849.
26. Sanchez Mas J, Olivares Sanchez C, Ghanem G, et al. Loss-of-function variants of the human melanocortin-1 receptor gene in melanoma cells define structural determinants of receptor function. Eur J Biochem 2002; 269: 6133-6141.
27. Cabrera de Leon A, Gonzalez DA, Mendez LI, et al. Leptin and altitude in the cardiovascular diseases. Obes Res 2004; 12: 1492-1498.
28. Cabrera de Leon A, Rodriguez-Perez MC, del Castillo-Rodriguez JC, et al. [Coronary risk in the population of the Canary Islands, Spain, using the Framingham function]. Med Clin (Barc) 2006; 126: 521-526.
29. Maca-Meyer N, Villar J, Perez-Mendez L, et al. A tale of aborigines, conquerors and slaves: Alu insertion polymorphisms and the peopling of Canary Islands. Ann Hum Genet 2004; 68: 600-605.
30. Rozen S, Skaletsky H. Primer 3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132: 365-386.
31. Kaderali L, Deshpande A, Nolan JP, et al. Primer-design for multiplexed genotyping. Nucleic Acids Res 2003; 31: 1796-1802.
32. Raymond M, Rousset F. GENEPOP (ver 1.1.2): Population genetics software for exact tests and ecumenicism. J Hered 1995; 86: 248-249.
33. Scheet P, Stephens M. A fast and flexible statistical model for large-scale population genotype data: Applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet 2006; 78: 629-644.
34. Brash DE. Sunlight and the onset of skin cancer. Trends Genet 1997; 13: 410-414.
35. English DR, Armstrong BK, Kricker A, et al. Sunlight and cancer. Cancer Causes Control 1997; 8: 271-283.
36. Kricker A, Armstrong BK, English DR. Sun exposure and non-melanocytic skin cancer. Cancer Causes Control 1994; 5: 367-392.
37. Koh HK, Geller AC, Miller DR, et al. Prevention and early detection strategies for melanoma and skin cancer. Current status. Arch Dermatol 1996; 132: 436-443.
38. Auerbach H. Geographic variation in incidence of skin cancer in the United States. Pub Health Rep 1961; 76: 45-48.
39. Fears TR, Scotto J, Schneiderman MA. Mathematical models of age and ultraviolet effects on the incidence of skin cancer among whites in the United States. Am J Epidemiol 1977; 105: 420-427.
40. Scotto J, Kopf AW, Urbach F. Non-melanoma skin cancer among Caucasians in four areas of the United States. Cancer 1974; 34: 1333-1338.
41. Gerstenblith MR, Goldstein AM, Fargnoli MC, et al. Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum Mutat 2007; 29: 495-505.
42. Fernandez LP, Milne RL, Bravo J, et al. MC1R: Three novel variants identified in a malignant melanoma association study in the Spanish population. Carcinogenesis 2007; 28: E1-e6.
43. Dwyer T, Stankovich JM, Blizzard L, et al. Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype? Am J Epidemiol 2004; 159: 826-833.